SEC Form 4 · accession 0001209191-17-021388
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glenn Coleman
Officer — CVP, CHIEF FINANCIAL OFFICER
Period of report
Mar 15, 2017
Accepted (ET)
Mar 17, 2017 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 15, 2017 | S | 4,462 | $43.1944 | D | 40,309 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price shown above represents the weighted average price of the shares sold. The range of sale prices was $43.1901 to $43.2106.